Microvesicles from platelets: novel drivers of vascular inflammation

Area of Science:

• Cardiovascular Biology
• Immunology
• Cell Biology

Background:

• Microvesicles are increasingly recognized for their roles in intercellular communication and disease pathogenesis.
• Platelets are a significant source of microvesicles, releasing them spontaneously or upon activation.
• Platelet-derived microvesicles (PDMV) retain characteristics of their parent cells and influence vascular and immune cells.

Purpose of the Study:

• To review the multifaceted aspects of platelet-derived microvesicles.
• To discuss the release, clearance, and measurement of PDMVs.
• To examine the occurrence of PDMVs in disease and their relevance to vascular inflammation.

Main Methods:

• This is a review article, synthesizing existing research.
• Literature search on platelet microvesicles, biomarkers, cell communication, and cardiovascular disease.
• Analysis of studies detailing PDMV release, function, and clinical relevance.

Main Results:

• Platelet-derived microvesicles are implicated as both biomarkers and mediators in various diseases, notably cardiovascular conditions.
• Elevated levels of PDMVs are observed in patients with cardiovascular disease.
• PDMV possess immunomodulatory functions affecting diverse cell types.

Conclusions:

• Platelet-derived microvesicles are crucial players in cell communication and disease pathophysiology.
• Understanding PDMVs is vital for developing new diagnostic and therapeutic strategies for vascular inflammation and cardiovascular disease.
• Further research into PDMV release, clearance, and measurement is warranted.